These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 36590607)

  • 21. Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis.
    Berger GE; Smesny S; Schäfer MR; Milleit B; Langbein K; Hipler UC; Milleit C; Klier CM; Schlögelhofer M; Holub M; Holzer I; Berk M; McGorry PD; Sauer H; Amminger GP
    PLoS One; 2016; 11(2):e0148429. PubMed ID: 26894921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antisaccade task performance in patients at ultra high risk for developing psychosis.
    Nieman D; Becker H; van de Fliert R; Plat N; Bour L; Koelman H; Klaassen M; Dingemans P; Niessen M; Linszen D
    Schizophr Res; 2007 Sep; 95(1-3):54-60. PubMed ID: 17656071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis.
    Garner B; Pariante CM; Wood SJ; Velakoulis D; Phillips L; Soulsby B; Brewer WJ; Smith DJ; Dazzan P; Berger GE; Yung AR; van den Buuse M; Murray R; McGorry PD; Pantelis C
    Biol Psychiatry; 2005 Sep; 58(5):417-23. PubMed ID: 16026767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurocognitive predictors of transition to psychosis: medium- to long-term findings from a sample at ultra-high risk for psychosis.
    Lin A; Yung AR; Nelson B; Brewer WJ; Riley R; Simmons M; Pantelis C; Wood SJ
    Psychol Med; 2013 Nov; 43(11):2349-60. PubMed ID: 23388122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in inflammatory balance correlates with conversion to psychosis among individuals at clinical high-risk: A prospective cohort study.
    Zhang T; Zeng J; Wei Y; Ye J; Tang X; Xu L; Hu Y; Cui H; Xie Y; Tang Y; Liu X; Liu H; Chen T; Li C; Wang J
    Psychiatry Res; 2022 Dec; 318():114938. PubMed ID: 36334327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-stigma and cognitive insight in individuals at ultra-high risk for psychosis.
    Sportel BE; van Enthoven M; van Donkersgoed RJM; Kuis DJ; van de Giessen T; Lysaker PH; Hasson-Ohayon I; de Jong S; Boonstra N; Pijnenborg GHM
    Front Psychiatry; 2023; 14():1154284. PubMed ID: 37124265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammation in first-episode psychosis: The contribution of inflammatory biomarkers to the emergence of negative symptoms, a systematic review and meta-analysis.
    Dunleavy C; Elsworthy RJ; Upthegrove R; Wood SJ; Aldred S
    Acta Psychiatr Scand; 2022 Jul; 146(1):6-20. PubMed ID: 35202480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in omega-3 and omega-6 polyunsaturated fatty acid consumption in people at ultra-high risk of psychosis, first-episode schizophrenia, and in healthy controls.
    Pawełczyk T; Trafalska E; Pawełczyk A; Kotlicka-Antczak M
    Early Interv Psychiatry; 2017 Dec; 11(6):498-508. PubMed ID: 26279283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered depth of the olfactory sulcus in ultra high-risk individuals and patients with psychotic disorders.
    Takahashi T; Wood SJ; Yung AR; Nelson B; Lin A; Yücel M; Phillips LJ; Nakamura Y; Suzuki M; Brewer WJ; Proffitt TM; McGorry PD; Velakoulis D; Pantelis C
    Schizophr Res; 2014 Mar; 153(1-3):18-24. PubMed ID: 24530137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipsychotics Do Not Influence Neurological Soft Signs in Children and Adolescents at Ultra-High Risk for Psychosis: A Pilot Study.
    Pitzianti M; Casarelli L; Pontillo M; Vicari S; Armando M; Pasini A
    J Psychiatr Pract; 2019 May; 25(3):186-191. PubMed ID: 31083030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insular cortex gray matter changes in individuals at ultra-high-risk of developing psychosis.
    Takahashi T; Wood SJ; Yung AR; Phillips LJ; Soulsby B; McGorry PD; Tanino R; Zhou SY; Suzuki M; Velakoulis D; Pantelis C
    Schizophr Res; 2009 Jun; 111(1-3):94-102. PubMed ID: 19349150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensory gating in subjects at ultra high risk for developing a psychosis before and after a first psychotic episode.
    van Tricht MJ; Nieman DH; Koelman JT; Mensink AJ; Bour LJ; van der Meer JN; van Amelsvoort TA; Linszen DH; de Haan L
    World J Biol Psychiatry; 2015 Jan; 16(1):12-21. PubMed ID: 22730901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma cytokines, cytokine antagonists, and disease progression in African women infected with HIV-1.
    Thea DM; Porat R; Nagimbi K; Baangi M; St Louis ME; Kaplan G; Dinarello CA; Keusch GT
    Ann Intern Med; 1996 Apr; 124(8):757-62. PubMed ID: 8633837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive deficits in clinical and familial high risk groups for psychosis are common as in first episode schizophrenia.
    Üçok A; Direk N; Koyuncu A; Keskin-Ergen Y; Yüksel Ç; Güler J; Karadayı G; Akturan E; Devrim-Üçok M
    Schizophr Res; 2013 Dec; 151(1-3):265-9. PubMed ID: 24262680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-reduction in hippocampal volume is associated with higher risk of psychosis.
    Phillips LJ; Velakoulis D; Pantelis C; Wood S; Yuen HP; Yung AR; Desmond P; Brewer W; McGorry PD
    Schizophr Res; 2002 Dec; 58(2-3):145-58. PubMed ID: 12409154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability.
    Solmi M; Suresh Sharma M; Osimo EF; Fornaro M; Bortolato B; Croatto G; Miola A; Vieta E; Pariante CM; Smith L; Fusar-Poli P; Shin JI; Berk M; Carvalho AF
    Brain Behav Immun; 2021 Oct; 97():193-203. PubMed ID: 34332041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immuno-inflammatory changes across phases of early psychosis: The impact of antipsychotic medication and stage of illness.
    Kelsven S; de la Fuente-Sandoval C; Achim CL; Reyes-Madrigal F; Mirzakhanian H; Domingues I; Cadenhead K
    Schizophr Res; 2020 Dec; 226():13-23. PubMed ID: 32089474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adolescents at ultra-high risk of psychosis in Italian neuropsychiatry services: prevalence, psychopathology and transition rate.
    Pelizza L; Azzali S; Garlassi S; Paterlini F; Scazza I; Chiri LR; Pupo S; Raballo A
    Eur Child Adolesc Psychiatry; 2018 Jun; 27(6):725-737. PubMed ID: 29058115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine profile in first-episode psychosis, unaffected siblings and community-based controls: the effects of familial liability and childhood maltreatment.
    Corsi-Zuelli F; Loureiro CM; Shuhama R; Fachim HA; Menezes PR; Louzada-Junior P; Mondelli V; Del-Ben CM
    Psychol Med; 2020 May; 50(7):1139-1147. PubMed ID: 31064423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mismatch Negativity Predicts Remission and Neurocognitive Function in Individuals at Ultra-High Risk for Psychosis.
    Fujioka M; Kirihara K; Koshiyama D; Tada M; Nagai T; Usui K; Morita S; Kawakami S; Morita K; Satomura Y; Koike S; Suga M; Araki T; Kasai K
    Front Psychiatry; 2020; 11():770. PubMed ID: 32848939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.